Performance Optimization
Growth hormone production declines after your mid-20s — reducing recovery capacity, lean body composition, and training output year over year. Peptide therapy restores natural GH pulsatility and metabolic efficiency without exogenous hormones.
Check Your Eligibility →Growth hormone is the master regulator of recovery, body composition, and physical performance. After your mid-20s, GH output declines approximately 14% per decade. By 40, most adults have lost nearly half their peak production. The consequences are measurable: slower recovery, increased body fat, reduced muscle protein synthesis, and declining training capacity.
Exogenous GH replacement carries significant risks and regulatory complexity. GH secretagogues like Ipamorelin and CJC-1295 offer a fundamentally different approach — they stimulate your pituitary to release growth hormone in natural, pulsatile patterns that preserve the body's feedback mechanisms. MOTS-C adds metabolic optimization via AMPK activation, improving cellular energy efficiency and fat oxidation.
Three peptides targeting growth hormone, metabolic efficiency, and training output.
Selective growth hormone secretagogue that stimulates natural GH release from the pituitary without raising cortisol or prolactin levels.
GHRH analogue that extends the growth hormone pulse when paired with Ipamorelin, providing sustained anabolic signaling over a longer recovery window.
Mitochondria-derived peptide that activates AMPK signaling, improving metabolic efficiency, fat oxidation, and cellular energy production.
Complete a brief online health questionnaire. Our medical team reviews your history, performance goals, and current medications to determine eligibility.
A licensed physician reviews your intake and prescribes a personalized performance-optimization peptide protocol. Your prescription is sent to a licensed 503a/503b compounding pharmacy.
Your peptides are compounded fresh, packed discreetly, and shipped directly to your door — typically within 48 hours of pharmacy processing.
No. Ipamorelin is a growth hormone secretagogue — it stimulates your pituitary gland to produce and release its own growth hormone in a natural, pulsatile pattern. This is fundamentally different from injecting exogenous (synthetic) GH, which bypasses the body's feedback mechanisms. Ipamorelin preserves the natural regulatory loop, does not significantly raise cortisol or prolactin, and has a much more favorable safety profile than exogenous GH replacement.
Many patients report improved sleep quality within the first 1–2 weeks, which is often the earliest sign that the GH pathway is responding. Body composition changes, improved recovery between sessions, and increased training capacity typically become noticeable at 4–6 weeks. Full optimization of GH pathways usually requires 8–12 weeks of consistent use. Your physician will monitor progress and adjust the protocol as needed.
MOTS-C is a mitochondria-derived peptide that activates AMPK (AMP-activated protein kinase), the body's master metabolic regulator. AMPK activation improves cellular energy production, enhances fat oxidation, and supports glucose metabolism. For performance, this translates to improved metabolic efficiency during exercise, better body composition, and enhanced recovery. Research suggests MOTS-C levels decline with age, making supplementation potentially valuable for athletes over 30.
GH secretagogues like Ipamorelin and CJC-1295 are prohibited by WADA (World Anti-Doping Agency) and most professional and collegiate sports organizations. If you compete in a tested sport, peptide therapy may not be appropriate for you. Standard workplace drug tests do not typically screen for peptides. Your prescribing physician will discuss this during your consultation. OrderlyPeptides is designed for recreational athletes and health-optimizing adults, not competitive athletes subject to anti-doping regulations.
Ipamorelin and CJC-1295 are commonly prescribed in cycles (typically 8–12 weeks on, followed by a break), though some physicians prescribe continuous low-dose protocols for patients with significant GH decline. The cycling approach helps maintain pituitary sensitivity and ensures the body's natural feedback mechanisms remain intact. MOTS-C is a naturally occurring peptide and may be used more continuously under physician supervision. Your protocol will be tailored to your specific situation and monitored with periodic bloodwork.
A physician is ready to evaluate your eligibility for performance-optimization peptide therapy — at no cost to start.
Check Your Eligibility →